Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis?

被引:39
|
作者
Smith, A
Lamagni, TL
Oliver, I
Efstratiou, A
George, RC
Stuart, JM
机构
[1] Hlth Protect Agcy, Ctr Infect, Healthcare Associated Infect & Antimicrobial Resi, London NW9 5EQ, England
[2] Hlth Protect Agcy, Ctr Infect, Streptococcus & Diphtheria Ref Lab, London, England
来源
LANCET INFECTIOUS DISEASES | 2005年 / 5卷 / 08期
关键词
D O I
10.1016/S1473-3099(05)70190-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Group A streptococci (Streptococcus pyogenes) causes a wide range of illnesses from non-invasive disease g, pharyngitis-to more severe invasive infections-eg, necrotising fasciitis and toxic shock-like syndrome. There remains uncertainty about the risk of secondary cases of invasive disease occurring among close contacts of an index case and how best to manage that risk. We do not consider that currently available evidence justifies the routine administration of chemoprophylaxis to close contacts. We suggest that the appropriate response should be to routinely inform all household contacts of a patient with invasive group A streptococcal disease about the clinical manifestations of invasive disease and to seek immediate medical attention if they develop such symptoms.
引用
收藏
页码:494 / 500
页数:7
相关论文
共 50 条
  • [2] Invasive group A streptococcal disease in the Northern Territory and the impact of melioidosis antibiotic prophylaxis
    Birrell, Johanna M.
    Boyd, Rowena
    Currie, Bart J.
    Anstey, Nicholas M.
    Abeyaratne, Asanga
    Majoni, Sandawana William
    Krause, Vicki L.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2022, 217 (10) : 544 - 545
  • [3] Antibiotic prophylaxis for neonatal group B streptococcal disease
    Walker, T
    Estrada, B
    [J]. INFECTIONS IN MEDICINE, 2001, 18 (09) : 419 - +
  • [4] Prevention of invasive group A streptococcal disease among household contacts of case-patients - Is prophylaxis warranted?
    Birkhead, G
    Cartter, ML
    Facklam, R
    Gerber, MA
    Green, K
    Hierholzer, W
    Jarvis, W
    Kaplan, EL
    Levine, OS
    MacDonald, KL
    McGeer, A
    Schwartz, B
    Shulman, ST
    Stevens, D
    Yogev, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15): : 1206 - 1210
  • [5] Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
    Schrag, SJ
    Zywicki, S
    Farley, MM
    Reingold, AL
    Harrison, LH
    Lefkowitz, LB
    Hadler, JL
    Danila, R
    Cieslak, PR
    Schuchat, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (01): : 15 - 20
  • [6] Effectiveness and Safety of Antibiotic Prophylaxis for Persons Exposed to Cases of Invasive Group A Streptococcal Disease: A Systematic Review
    Khan, Faizan
    Bai, Zemin
    Kelly, Shannon
    Skidmore, Becky
    Dickson, Catherine
    Nunn, Alexandra
    Rutledge-Taylor, Katie
    Wells, George
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (08):
  • [7] Streptococcal toxic shock syndrome after a dental implant treatment: Should patients receive antibiotic prophylaxis?
    Diederen, B. M. W.
    Buiting, Anton G.
    Spooren, Pieter F. M. J.
    [J]. JOURNAL OF INFECTION, 2006, 53 (03) : 211 - 212
  • [8] Recurrent group B streptococcal disease in infants: Who should receive rifampin?
    Atkins, JT
    Heresi, GP
    Coque, TM
    Baker, CJ
    [J]. JOURNAL OF PEDIATRICS, 1998, 132 (03): : 537 - 539
  • [9] Who should receive antibiotic prophylaxis before ERCP?
    Deviere, Jacques
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (11): : 594 - 595
  • [10] Who should receive antibiotic prophylaxis before ERCP?
    Jacques Devière
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 : 594 - 595